RBL Communications
RBL
Communications
Media Solutions For Public Companies
Gain access to millions of online investors with our targeted campaigns.
Social Media
We manage your social media channels, so you can concentrate on running your business.
Web Design
Showcase your company with a new modern website, designed to attract investors.
Advertising
We tell your story to millions of exclusively targeted investors globally.
Email Management
We manage your investor email list.
Reporting
We Quantify the performance of the program.
newsroom
Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development
Revive Therapeutics a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders.
Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents
Revive Therapeutics a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders.
Anfield Completes Acquisition of Uranium Project with Historical Indicated Uranium Resource of 18.1 Million Pounds
PSE has also secured original schematics of the entire uranium mill which has resulted in a more comprehensive and accelerated technical review.
PharmaDrug Announces Strategic Investment in Sairiyo Therapeutics Inc.
Completes clinical trial-scale production of cGMP Cepharanthine-2HCL drug substance.